Guichi Zhou
Overview
Explore the profile of Guichi Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang X, Liu S, Hu Y, Chen F, Wang L, Li T, et al.
Ann Hematol
. 2024 Dec;
104(1):559-564.
PMID: 39668199
Blinatumomab has shown to improve survival outcomes in B-cell acute lymphoblastic leukemia (B-ALL) patients with measurable residual disease (MRD) detected by multiparametric flow cytometry (MFC). However, data on blinatumomab clearing...
2.
Xie L, Xu Y, Zhou G, Chen F, Li C, Ma L, et al.
Front Pediatr
. 2024 Sep;
12:1448445.
PMID: 39318612
Background: The appearance of cerebral venous sinus thrombosis (CVST) in childhood acute lymphocytic leukemia (ALL) is a rare life-threatening disease that can cause significant morbidity, neurological sequelae, and potentially poor...
3.
Li T, Tang X, He X, Zhang L, Zhang Y, Wang L, et al.
Front Oncol
. 2024 Jun;
14:1391768.
PMID: 38939339
Objective: This study aims to elucidate the clinical features observed in cases of pediatric acute myeloid leukemia (AML) initially presenting with cardiac tamponade and to share treatment experiences. Materials And...
4.
Tang X, Mai H, Wang L, Chen S, Chen F, Li T, et al.
BMC Pediatr
. 2024 Mar;
24(1):204.
PMID: 38519960
Background: Central nervous system leukemia (CNSL) is one of the major causes of the poor prognosis of childhood leukemia. We aimed to compare the sensitivity of cytomorphology (CM) and flow...
5.
Wang L, Tang X, Zhou G, Liu S, Wang Y, Chen F, et al.
J Oncol
. 2022 Oct;
2022:5896022.
PMID: 36276286
The prognosis of over 90% of infant acute lymphoblastic leukemia (ALL) remains poor because of harboring the mixed-lineage leukemia gene () fusion. To give insight into the critical coexpressed genes...
6.
Mai H, Li Q, Wang G, Wang Y, Liu S, Tang X, et al.
J Cancer Res Clin Oncol
. 2022 Aug;
149(7):3259-3266.
PMID: 35918464
Background: Next-generation sequencing (NGS) is an emerging technology that can comprehensively assess the diversity of the immune system. We explored the feasibility of NGS in detecting minimal residual disease (MRD)...
7.
Wang L, Yan D, Tang X, Zhang M, Liu S, Wang Y, et al.
Front Oncol
. 2021 Dec;
11:755188.
PMID: 34938655
Background: Despite much improvement in the treatment for acute lymphoblastic leukemia (ALL), childhood ALLs with -rearrangement (-r) still have inferior dismal prognosis. Thus, defining mechanisms underlying -r ALL maintenance is...
8.
Xie L, Long Q, Zhou G, Liu S, Wen F
Ital J Pediatr
. 2021 Feb;
47(1):27.
PMID: 33573668
Background: Invasive fungal infection (IFI) is one of the most challenging complications in children undergoing acute lymphoblastic leukaemia (ALL) treatment, but acute fungal osteomyelitis (OM) is rarely encountered. Case Presentation:...
9.
Zhang C, Zhou G, Chen Y, Liu S, Chen F, Xie L, et al.
Mol Med Rep
. 2017 Nov;
17(1):71-78.
PMID: 29115435
Dilated cardiomyopathy (DCM) is a disease of the heart characterized by pathological remodeling, including patchy interstitial fibrosis and degeneration of cardiomyocytes. In the present study, the beneficial role of human...
10.
Zhang C, Zhou G, Cai C, Li J, Chen F, Xie L, et al.
Mol Med Rep
. 2017 Apr;
15(6):3515-3520.
PMID: 28440472
Acute myocarditis is a non-ischemic inflammatory disease of the myocardium, and there is currently no standard treatment. Mesenchymal stem cells (MSCs) can alleviate myosin‑induced myocarditis; however, the mechanism has not...